Format

Send to

Choose Destination
PLoS One. 2011;6(12):e27967. doi: 10.1371/journal.pone.0027967. Epub 2011 Dec 9.

Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists.

Author information

1
Departments of Neuroscience and Cell Biology, The University of Texas Medical Branch, Galveston, Texas, United States of America.

Erratum in

  • PLoS One. 2012;7(5): doi/10.1371/annotation/81d01b33-4eb2-459c-b600-0094d9f2d194.

Abstract

CXCL8/interleukin-8 is a pro-inflammatory chemokine that triggers pleiotropic responses, including inflammation, angiogenesis, wound healing and tumorigenesis. We engineered the first selective CXCR1 agonists on the basis of residue substitutions in the conserved ELR triad and CXC motif of CXCL8. Our data reveal that the molecular mechanisms of activation of CXCR1 and CXCR2 are distinct: the N-loop of CXCL8 is the major determinant for CXCR1 activation, whereas the N-terminus of CXCL8 (ELR and CXC) is essential for CXCR2 activation. We also found that activation of CXCR1 cross-desensitized CXCR2 responses in human neutrophils co-expressing both receptors, indicating that these novel CXCR1 agonists represent a new class of anti-inflammatory agents. Further, these selective CXCR1 agonists will aid at elucidating the functional significance of CXCR1 in vivo under pathophysiological conditions.

PMID:
22174759
PMCID:
PMC3235101
DOI:
10.1371/journal.pone.0027967
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center